Efficacy and tolerability of duloxetine in elderly patients with generalized anxiety disorder: A pooled analysis of four randomized, double-blind, placebo-controlled studies

Human Psychopharmacology

Volumn 23, Issue 6, 2008, Pages 519-526

  Davidson, Jonathan ^a,g   Allgulander, Christer ^b   Pollack, Mark H ^c   Hartford, James ^d   Erickson, Janelle S ^e   Russell, James M ^e   Perahia, David ^e,f   Wohlreich, Madalaine M ^e   Carlson, Janice ^e   Raskin, Joel ^e  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d Community Research ^*  (United States)

^e ELI LILLY AND COMPANY   (United States)

^f Gordon Hospital   (United Kingdom)

^g Gordon Hospital ^*  (United States)

Author keywords

Duloxetine; Efficacy; Elderly; Generalized anxiety disorder; Tolerability

Indexed keywords

DULOXETINE; PLACEBO; VENLAFAXINE;

ADULT; AGED; ANXIETY; ARTICLE; CLINICAL TRIAL; CONSTIPATION; DEPRESSION; DIARRHEA; DIZZINESS; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG TOLERABILITY; DRUG WITHDRAWAL; FATIGUE; FEMALE; GENERALIZED ANXIETY DISORDER; HAMILTON ANXIETY SCALE; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; HYPERHIDROSIS; MALE; META ANALYSIS; NAUSEA; ORTHOSTATIC HYPOTENSION; PRIORITY JOURNAL; SIDE EFFECT; SOMNOLENCE; SYSTEMATIC REVIEW; URINARY DYSFUNCTION; VOMITING; XEROSTOMIA;

ADRENERGIC UPTAKE INHIBITORS; AGED; ANXIETY DISORDERS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SEROTONIN UPTAKE INHIBITORS; THIOPHENES;

EID: 51049108533     PISSN: 08856222     EISSN: 10991077     Source Type: Journal    
DOI: 10.1002/hup.949     Document Type: Article

References (32)

1. Allgulander C, Lavori PW. 1991. Excess mortality among 3302 patients with 'pure' anxiety neurosis. Arch Gen Psychiatry 48: 599-602.
2. Allgulander C, Lavori PW. 1993. Causes of death among 936 elderly patients with 'pure' anxiety neurosis in Stockholm County, Sweden, and in patients with depressive neurosis or both diagnoses. Compr Psychiatry 34: 299-302.
3. Alwahhabi F. 2003. Anxiety symptoms and generalized anxiety disorder in the elderly: a review. Harv Rev Psychiatry 11: 180-193.
4. American Psychiatric Association (APA). 2000. Diagnostic and Statistical Manual of Mental Disorders. 4th edition, text revision (DSM-IV-TR).
5. Beekman AT, de Beurs E, van Balkom AJ, Deeg DJ, van Dyck R, van Tilburg W. 2000. Anxiety and depression in later life: co-occurrence and communality of risk factors. Am J Psychiatry 157: 89-95.
6. Blazer D, Burchett B, Service C, George LK. 1991. The association of age and depression among the elderly: an epidemiologic exploration. J Gerontol 46: M210-M215.
7. Bogunovic OJ, Greenfield SF. 2004. Practical geriatrics: use of benzodiazepines among elderly patients. Psychiatr Serv 55: 233-235.
8. Copeland JR, Dewey ME, Wood N, Searle R, Davidson IA, McWilliam C. 1987. Range of mental illness among the elderly in the community. Prevalence in Liverpool using the GMS-AGECAT package. Br J Psychiatry 150: 815-823.
9. Flint AJ, Rifat SL. 1997. Anxious depression in elderly patients. Response to antidepressant treatment. Am J Geriatr Psychiatry 5: 107-115.
10. Guy W. 1976. ECDEU Assessment Manual for Psychopharmacology, Revised (DHEW Publ No ADM 76-338). U.S. Department of Health, Education, and Welfare, Public Health Service, Alcohol, Drug Abuse, and Mental Health Administration, NIMH Psychopharmacology Research Branch, Division of Extramural Research Programs, Rockville, MD.
11. Hamilton M. 1959. The assessment of anxiety states by rating. Br J Med Psychol 32: 50-55.
12. Hartford J, Kornstein S, Liebowitz MR, et al. 2007. Duloxetine as an SNRI treatment for generalized anxiety disorder: results from a placebo and active-controlled trial. Int Clin Psychopharmacology 22: 167-174.
13. Himmelfarb S, Murrell SA. 1984. The prevalence and correlates of anxiety symptoms in older adults. J Psychol 116: 159-167.
14. Koponen H, Allgulander C, Erickson J, et al. 2007. Efficacy of duloxetine for the treatment of generalized anxiety disorder: implications for primary care physicians. Prim Care Companion J Clin Psychiatry 9: 100-107.
15. Le Roux H, Gatz M, Wetherell JL. 2005. Age at onset of generalized anxiety disorder in older adults. Am J Geriatr Psychiatry 13: 23-30.
16. Lenze EJ, Mulsant BH, Shear MK, et al. 2000. Comorbid anxiety disorders in depressed elderly patients. Am J Psychiatry 157: 722-728.
17. Linjakumpu T, Hartikainen S, Klaukka T, Veijola J, Kivela SL, Isoaho R. 2002. Use of medications and polypharmacy are increasing among the elderly. J Clin Epidemiol 55: 809-817.
18. Lipman RS, Covi L, Downing RW, et al. 1981. Pharmacotherapy of anxiety and depression: rationale and study design. Psychopharmacol Bull 17: 91-103.
19. Lipsitz J, Kobak K, Feiger A, Sikich D, Moroz G, Engelhard A. 2004. The rater applied performance scale: development and reliability. Psychiatry Res 127: 147-155.
20. Nicolini H, Bakish D, Duenas H, et al. 2008. Improvement of psychic and somatic symptoms in adult patients with generalized anxiety disorder: examination from a duloxetine, venlafaxine extended-release, and placebo-controlled trial. Psychol Med. (in press).
21. Raskin A, Schulterbrandt J, Reating N, McKeon JJ. 1969. Replication of factors of psychopathology in interview, ward behavior and self-report ratings of hospitalized depressives. J Nerv Ment Dis 148: 87-98.
22. Raskin J, Wiltse CG, Siegal A, et al. 2007. Efficacy of duloxetine on cognition, depression, and pain in elderly patients with major depressive disorder: an 8-week, double-blind, placebo-controlled trial. Am J Psychiatry 164: 900-909.
23. Russell JM, Weisberg R, Fava M, Hartford JT, Erickson JS, D'Souza DN. 2007. Efficacy of duloxetine in the treatment of generalized anxiety disorder in patients with clinically significant pain symptoms. Depress Anxiety Jun 22. [Epub ahead of print]
24. Rynn M, Russell J, Erickson J, et al. 2008. Efficacy and safety of duloxetine in the treatment of generalized anxiety disorder: a flexible-dose, progressive-titration, placebo-controlled trial. Depress Anxiety Feb 20. [Epub ahead of print]
25. Schneider LS. 1996. Overview of generalized anxiety disorder in the elderly. J Clin Psychiatry 57: 34-45.
26. Shear MK, Vander BJ, Rucci P, et al. 2001. Reliability and validity of a structured interview guide for the Hamilton anxiety rating scale (SIGH-A). Depress Anxiety 13: 166-178.
27. Sheehan DV. 1983. Sheehan disability scale. In Handbook of Psychiatric Measures. American Psychiatric Association: Washington, DC; 113-115.
28. Sheehan DV, Lecrubier Y, Harnett-Sheehan KH, et al. 1998. The mini-international neuropsychiatric interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and LCD-10. J Clin Psychiatry 59: 22-33.
29. Turnheim K. 2003. When drug therapy gets old: pharmacokinetics and pharmacodynamics in the elderly. Exp Gerontol 38: 843-853.
30. Wetherell JL, Thorp SR, Patterson TL, Golshan S, Jeste DV, Gatz M. 2004. Quality of life in geriatric generalized anxiety disorder: a preliminary investigation. J Psychiatr Res 38: 305-312.
31. Wise TN, Wiltse CG, Iosifescu DV, Sheridan M, Xu JY, Raskin J. 2007. The safety and tolerability of duloxetine in depressed elderly patients with and without medical comorbidity. Int J Clin Pract 61: 1283-1293.
32. Zigmond AS, Snaith RP. 1983. The hospital anxiety and depression scale. Acta Psychiatr Scand 67: 361-370.